T63166 |
LSN3318839
|
2764704-18-7
|
98%
|
|
LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and can be...
|
T60047 |
V-0219
|
878453-71-5
|
98%
|
|
V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes.
|
TP2252 |
GLP-1 (9-36) amide
|
161748-29-4
|
98%
|
|
antagonist at the human GLP-1 receptor
|
TP1976L |
Oxyntomodulin acetate
|
|
98%
|
|
Oxyntomodulin acetate, a 37-amino acid peptide hormone, is a glucagon-like peptide 1 (GLP-1) receptor agonist[1].
|
TP1148L |
Glucagon-like peptide 1 (1-37), human acetate
|
|
98%
|
|
Glucagon-like peptide 1 (1-37), human acetate is a highly potent the GLP-1 receptor agonist.
|
TP1452L1 |
HAEGTFTSD acetate(926018-45-3 free base)
|
TP1452L1
|
98%
|
|
HAEGTFTSD acetate is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from in...
|
T12878 |
Semaglutide TFA (910463-68-2 free base)
|
T12878
|
98%
|
|
Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment.
|
T35337 |
Teduglutide
|
197922-42-2
|
98%
|
|
|
T9226 |
CCG-143140
|
891016-02-7
|
98%
|
|
CCG-143140 is a GLP-1 receptor inverse agonists.
|
TP1469 |
Lixisenatide acetate (320367-13-3 free base)
|
1997361-87-1
|
98%
|
|
Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
|
T3984 |
GLP-1(7-36), amide
|
107444-51-9
|
98%
|
|
GLP-1 (7-36) amide is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays vari...
|
T3967 |
Exendin-4
|
141758-74-9
|
98%
|
|
Exendin-4 is a glucagon-like peptide-1 receptor (GLP-1) agonist (IC50: 3.22 nM). Exenatide is a 39 amino acid peptide. Compared to GLP-1, exenatide has a longer ...
|
T63166L |
(S, R)-LSN 3318839
|
2765539-92-0
|
98%
|
|
(S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in anima...
|
T19850 |
Semaglutide
|
910463-68-2
|
98%
|
|
Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).
|
T36579 |
GLP-1R Agonist DMB
|
281209-71-0
|
98%
|
|
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor).
|
T8876 |
PF-06882961 Tris
|
2230198-03-3
|
98%
|
|
PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
|
T8355 |
Exenatide acetate
|
141732-76-5
|
98%
|
|
Exendin-4 is a glucagon-like protein-1 (GLP-1) receptor agonist
|
T3896 |
Shanzhiside methyl ester
|
64421-28-9
|
98%
|
|
Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 ...
|
TQ0239 |
PF-06291874
|
1393124-08-7
|
98%
|
|
PF-06291874 (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor.
|
T12431 |
PF-06882961
|
2230198-02-2
|
98%
|
|
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
|